Scientists discover gene mutation that signals aggressive melanoma

Scientists discover gene mutation that signals aggressive melanoma
Graphical abstract. Credit: Cell Reports (2022). DOI: 10.1016/j.celrep.2022.110637

Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report.

The findings suggest that patients whose tumors have an ARID2 mutation may have a more and may need to be treated differently, according to a study published in Cell Reports in April.

"Our study is the first to characterize the tumor-suppressive functions of ARID2 in melanoma," said the study's lead author Emily Bernstein, Ph.D., Professor of Oncological Sciences at The Tisch Cancer Institute at Mount Sinai. "We modeled ARID2 mutations by removing the ARID2 protein completely from and studied the consequences in the petri dish and in animal models. Recreating actual mutations that patients harbor is challenging, but now possible by genome editing, and would further provide a more accurate model; such studies are ongoing in the lab."

Melanoma is the deadliest form of skin cancer, and develops in the cells that produce melanin, the pigment that gives people's skin its color. While melanoma can be treated successfully when caught early, it can also be quite aggressive and spread from tumors as small as a couple millimeters to vital organs like the brain. Understanding is essential to save lives from this disease, which affects 200,000 people a year worldwide.

ARID2 is part of a chromatin remodeling complex and frequently mutated in melanoma. In this study, scientists used melanoma tumor models to measure the role of the ARID2 gene in progression. They assessed the effects of ARID2 loss on the epigenetic landscape, a dynamic DNA and protein platform that They found that without ARID2, melanoma cells exhibit increased metastatic behaviors.

More information: Saul Carcamo et al, Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma, Cell Reports (2022). DOI: 10.1016/j.celrep.2022.110637

Journal information: Cell Reports
Citation: Scientists discover gene mutation that signals aggressive melanoma (2022, April 18) retrieved 22 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-snail axis


Feedback to editors